Barbara Burtness, Ari J. Rosenberg, Paul L. Swiecicki, Jessica L. Geiger, Marc Oliva, Xuesong Lyu, Joshua C. Curtin, Kiichiro Toyoizumi, John Xie, Mark Wade, Brooke Diorio, Aastha Kapoor, Emrullah Yilmaz, Mahadi Baig, Priya Kim, Remy B. Verheijen, Sujay Shah, Kevin J. Harrington, Cyril Abdeddaim, Douglas Adkins, Myung-Ju Ahn, Aarti Bhatia, Irene BraƱa, Benoit Calderon, Martin Forster, Jessica Geiger, Ye Guo, Dennis Hahn, Missak Haigentz, Kevin Harrington, Lara Iglesias, William Ince, Dongmei ji, Shigenori Kadowaki, Andrzej Kawecki, Bhumsuk Keam, Kathleen Kerrigan, Sung-Bae Kim, Shau-Hsuan Li, Sun Min Lim, Jin-Ching Lin, Lei Liu, Jessica McDermott, Robert Metcalf, Ewa Pawlowska, Ari Rosenberg, Tomasz Rutkowski, Malwinder Sandhu, Nisha Mohd Shariff, Siddharth Sheth, Alexander Spira, Ammar Sukari, Paul Loren Swiecicki, Hideki Tanaka, Caroline Viala, Zara Vidales, Hung-Ming Wang, Muh-Hwa Yang, Kunyu Yang. "Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study." Journal of Clinical Oncology, 2026. doi:10.1200/jco-26-01042